(Q40566351)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559808%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

title

Comparison of the reactogenicity and immunogenicity of a split and a subunit-adjuvanted influenza vaccine in elderly subjects (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559808%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559808%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

author name string

S Squarcione

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559808%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

S Sgricia

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559808%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

E Perinetti

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559808%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

language of work or name

English

0 references

publication date

1 March 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559808%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559808%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559808%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

issue

11-12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559808%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

page(s)

1268-1274

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559808%20AND%20SRC:MED&resulttype=core&format=json

Influenza: diagnosis, management, and prophylaxis

17 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900401-2

7 January 2021

Influenza vaccination and the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900401-2

7 January 2021

Frequency of adverse reactions after influenza vaccination

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900401-2

7 January 2021

Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900401-2

7 January 2021

The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900401-2

7 January 2021

The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900401-2

7 January 2021

Adjuvanted influenza vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900401-2

7 January 2021

The adjuvants MF59 and LT-K63 enhance the mucosal and systemic immunogenicity of subunit influenza vaccine administered intranasally in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900401-2

7 January 2021

Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900401-2

7 January 2021

Safety and immunogenicity of MF59-adjuvanted influenza vaccine in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900401-2

7 January 2021

Influenza vaccines: antibody responses to split virus and MF59-adjuvanted subunit virus in an adult population.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900401-2

7 January 2021

The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900401-2

7 January 2021

Role of influenza vaccination in the elderly during an epidemic of A/H1N1 virus in 1988-1989: clinical and serological data

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900401-2

7 January 2021

Immunogenicity of trivalent subunit and split influenza vaccines (1989-90 winter season) in volunteers of different groups of age

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900401-2

7 January 2021

Antibody induction by influenza vaccines in the elderly: a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900401-2

7 January 2021

Effects of repeated annual influenza vaccination on vaccine sero-response in young and elderly adults

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900401-2

7 January 2021

Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900401-2

7 January 2021

Split-virus influenza vaccines: do they provide adequate immunity in the elderly?

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900401-2

7 January 2021

10.1016/S0264-410X(02)00401-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12559808%20AND%20SRC:MED&resulttype=core&format=json

17 December 2019

1 reference